The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection
To access this article, please choose from the options below
PII: S0887-7963(97)80037-5
doi:10.1053/tmrv.1997.0110155
© 1997 Published by Elsevier Inc.
